// Cochlear Implantation in Sickle Cell Disease: A Systematic Review of Feasibility and Outcomes
系統性回顧分析4篇案例報告中5名鐮狀細胞病患者的感音神經性聽力損失與人工耳蝸植入｜結果顯示人工耳蝸植入技術可行，60%患者獲得明顯聽力改善｜但40%出現感染及肺栓塞等併發症，需加強圍手術期管理｜呼籲進行更大規模研究以評估風險與優化治療方案。
// This systematic review examined sensorineural hearing loss and cochlear implantation in sickle cell disease patients by analyzing four case reports with five patients. Cochlear implantation was technically feasible and resulted in improved hearing in most cases, but only 60% showed meaningful auditory benefits. Complications, including infection and pulmonary embolism, occurred in 40% of cases, indicating the need for careful perioperative management. Larger studies are necessary to better assess risks, effectiveness, and optimize treatment strategies for this population.
Published 2026年7月16日
// 正在尋找相關文獻...